RTX resiniferatoxin: Began Phase II study

Afferon Corp., Wayne, Penn. Product: RTX resiniferatoxin Business: Urological, Neurological Therapeutic category: Neurotransmission Target: Peripheral sensory neurons Description: Neuronal desensitizi...